| Literature DB >> 29164319 |
Cecilia Kullberg1, Tomas Andersson2,3, Per Gustavsson2,3, Jenny Selander2, Göran Tornling4, Annika Gustavsson2,3, Carolina Bigert2,3.
Abstract
OBJECTIVES: Previous studies on firefighters indicate an increased risk of cancer although findings regarding which cancer sites are in excess have been inconsistent. The aim of this study was to investigate the cancer incidence among Swedish firefighters.Entities:
Keywords: Carcinogens; Firefighters; Occupational exposure; Particles; Smoke
Mesh:
Year: 2017 PMID: 29164319 PMCID: PMC5845066 DOI: 10.1007/s00420-017-1276-1
Source DB: PubMed Journal: Int Arch Occup Environ Health ISSN: 0340-0131 Impact factor: 3.015
Characteristics of Stockholm firefighter cohort
| Min | Max | Mean | Median | |
|---|---|---|---|---|
| Birth year | 1881 | 1960 | 1925 | 1925 |
| Age at employment | 17 | 57 | 25 | 24 |
| Age at start of follow-up | 18 | 77 | 38 | 34 |
| Start of employment | 1902 | 1983 | 1951 | 1951 |
| End of employment or follow-up | 1933 | 2012 | 1977 | 1977 |
| Employment duration (years) | 1 | 44 | 26 | 30 |
Observed and expected cancer incidence in 1080 Stockholm firefighters for the full follow-up; 1958–2012, the former follow-up only; 1958–1986 and the extended follow-up only; 1987–2012
| Cancer location (ICD 7) | Full follow-up; 1958–2012 | Former follow-up only; 1958–1986 | Extended follow-up only; 1987–2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Obsa | Expb | SIRc | 95% CI | Obs | Exp | SIR | 95% CI | Obs | Exp | SIR | 95% CI | |
| Malignant tumor, total (140–209) | 265 | 327.9 | 0.81 | (0.71–0.91) | 130 | 126.0 | 1.03 | (0.86–1.23) | 135 | 201.9 | 0.67 | (0.56–0.79) |
| Lip (140) | 2 | 1.4 | 1.45 | (0.18–5.26) | 1 | 0.7 | 1.42 | (0.04–7.91) | 1 | 0.7 | 1.49 | (0.38–8.32) |
| Esophagus (150) | 5 | 5.1 | 0.99 | (0.32–2.30) | 1 | 2.3 | 0.43 | (0.01–2.38) | 4 | 2.7 | 1.46 | (0.40–3.75) |
| Stomach (151) | 27 | 14.5 | 1.89 | (1.25–2.75) | 20 | 9.1 | 2.21 | (1.35–3.41) | 7 | 5.2 | 1.35 | (0.54–2.78) |
| Colon (153) | 20 | 23.1 | 0.86 | (0.53–1.34) | 8 | 8.7 | 0.92 | (0.40–1.81) | 12 | 14.4 | 0.83 | (0.43–1.46) |
| Rectum and anus (154) | 18 | 14.4 | 1.25 | (0.74–1.98) | 10 | 5.8 | 1.74 | (0.83–3.19) | 8 | 8.6 | 0.93 | (0.40–1.82) |
| Biliary passages of liver (155) | 7 | 8.8 | 0.79 | (0.32–1.63) | 4 | 4.4 | 0.90 | (0.25–2.31) | 3 | 4.4 | 0.68 | (0.14–2.00) |
| Pancreas (157) | 10 | 9.5 | 1.06 | (0.51–1.94) | 6 | 4.9 | 1.23 | (0.45–2.68) | 4 | 4.6 | 0.87 | (0.24–2.23) |
| Bronchus and lung primary (1621) | 27 | 34.0 | 0.79 | (0.52–1.15) | 17 | 17.6 | 0.96 | (0.56–1.55) | 10 | 16.4 | 0.61 | (0.29–1.12) |
| Pleura (1622) | 2 | 0.8 | 2.41 | (0.29–8.71) | 1 | 0.2 | 5.24 | (0.13–29.19) | 1 | 0.64 | 1.57 | (0.04–8.73) |
| Prostate (177) | 60 | 88.6 | 0.68 | (0.52–0.87) | 29 | 24.3 | 1.19 | (0.80–1.72) | 31 | 64.3 | 0.48 | (0.33–0.69) |
| Kidney (180) | 6 | 10.6 | 0.57 | (0.21–1.23) | 2 | 5.4 | 0.37 | (0.04–1.33) | 4 | 5.2 | 0.78 | (0.21–1.99) |
| Urinary organs (181) | 16 | 22.3 | 0.72 | (0.41–1.17) | 8 | 8.4 | 0.95 | (0.41–1.88) | 8 | 13.9 | 0.58 | (0.25–1.14) |
| Malignant melanoma of skin (190) | 3 | 10.0 | 0.30 | (0.06–0.88) | 1 | 2.6 | 0.39 | (0.01–2.18) | 2 | 7.4 | 0.27 | (0.03–0.97) |
| Non-melanoma skin cancer (191) | 17 | 20.1 | 0.85 | (0.49–1.35) | 5 | 3.4 | 1.49 | (0.48–3.48) | 12 | 16.7 | 0.72 | (0.37–1.25) |
| Brain nervous system (193) | 8 | 6.9 | 1.16 | (0.50–2.28) | 6 | 3.6 | 1.68 | (0.62–3.66) | 2 | 3.4 | 0.60 | (0.07–2.15) |
| Endocrine glands (195) | 2 | 2.6 | 0.78 | (0.09–2.80) | 1 | 1.2 | 0.80 | (0.02–4.48) | 1 | 1.3 | 0.75 | (0.02–4.18) |
| Connective tissue muscle (197) | 3 | 1.9 | 1.56 | (0.32–4.55) | 1 | 0.8 | 1.26 | (0.03–7.04) | 2 | 1.1 | 1.76 | (0.21–6.36) |
| All haematopoietic cancer (200–209) | 18 | 24.6 | 0.73 | (0.43–1.16) | 3 | 9.7 | 0.31 | (0.06–0.90) | 15 | 14.9 | 1.01 | (0.56–1.66) |
| Malignant non-Hodgkin lymphoma (200) | 6 | 8.8 | 0.68 | (0.25–1.48) | 1 | 2.8 | 0.35 | (0.01–1.97) | 5 | 6.0 | 0.83 | (0.27–1.94) |
| Hodgkin’s disease (201) | 2 | 1.4 | 1.39 | (0.17–5.00) | 1 | 1.0 | 0.97 | (0.02–5.42) | 1 | 0.4 | 2.41 | (0.06–13.40) |
| Multiple myeloma, plasmocytoma (203) | 5 | 4.2 | 1.18 | (0.38–2.75) | 0 | 1.7 | 0.00 | (0.00–2.15) | 5 | 2.6 | 1.96 | (0.64–4.57) |
| Leukemia (204–207) | 3 | 8.0 | 0.38 | (0.08–1.10) | 1 | 3.4 | 0.29 | (0.01–1.62) | 2 | 4.6 | 0.43 | (0.05–1.59) |
aObserved number of cancer cases
bExpected number of cancer cases based on cancer incidence among all men living in Stockholm County
cStandardized Incidence Ratio
Cancer incidence in Stockholm firefighters 1958–2012 stratified by age, employment duration and starting year of employment
| Person-years | Total cancer | Stomach cancer | Prostate cancer | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Obsa | Expb | SIRc | 95% CI | Obs | Exp | SIR | 95% CI | Obs | Exp | SIR | 95% CI | ||
| Age (years) | |||||||||||||
| < 50 | 15,253 | 6 | 15.1 | 0.40 | (0.15–0.86) | 2 | 0.6 | 3.18 | (0.39–11.49) | 1 | 0.2 | 4.24 | (0.11–23.60) |
| 50–64 | 12,144 | 48 | 83.6 | 0.57 | (0.42–0.76) | 8 | 3.4 | 2.38 | (1.03–4.70) | 10 | 19.9 | 0.50 | (0.24–0.92) |
| ≥ 65 | 9093 | 211 | 229.1 | 0.92 | (0.80–1.05) | 17 | 10.3 | 1.65 | (0.96–2.65) | 49 | 68.3 | 0.72 | (0.53–0.95) |
| |
|
|
| ||||||||||
| Employment duration (years) | |||||||||||||
| 1–9 | 8612 | 18 | 38.0 | 0.47 | (0.30–0.75) | 0 | - | - | 7 | 11.0 | 0.64 | (0.30–1.33) | |
| 10–19 | 7857 | 20 | 30.4 | 0.66 | (0.42–1.02) | 2 | 1.0 | 2.02 | (0.50–8.06) | 3 | 7.4 | 0.41 | (0.13–1.26) |
| 20–29 | 8542 | 64 | 65.1 | 0.98 | (0.77–1.26) | 7 | 3.4 | 2.03 | (0.97–4.26) | 17 | 16.1 | 1.06 | (0.66–1.70) |
| ≥ 30 | 11,479 | 163 | 194.4 | 0.84 | (0.72–0.98) | 18 | 8.8 | 2.05 | (1.29–3.26) | 33 | 54.1 | 0.61 | (0.43–0.86) |
| |
|
|
| ||||||||||
| Starting year of employment | |||||||||||||
| 1902–1939 | 6706 | 116 | 115.0 | 1.01 | (0.84–1.21) | 15 | 8.3 | 1.81 | (1.09–3.01) | 24 | 27.4 | 0.87 | (0.59–1.31) |
| 1940–1959 | 12,912 | 122 | 135.9 | 0.90 | (0.75–1.07) | 8 | 4.5 | 1.77 | (0.88–3.55) | 31 | 35.7 | 0.87 | (0.61–1.23) |
| 1960–1983 | 16,872 | 27 | 76.9 | 0.35 | (0.24–0.51) | 4 | 1.5 | 2.72 | (1.02–7.26) | 5 | 25.4 | 0.20 | (0.08–0.47) |
| |
|
|
| ||||||||||
Italic values indicate P trend; < 0.05 was considered statistically significant
aObserved cancer cases
bExpected cancer cases
cStandardized Incidence Ratio